Related Experiment Video
Updated: Mar 10, 2026

Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI
Published on: October 20, 2023
Liver Function Assessment by Magnetic Resonance Imaging.
Emre Ünal1, Deniz Akata2, Musturay Karcaaltincaba2
1Liver Imaging Team, Department of Radiology, Hacettepe University, School of Medicine, Ankara, Turkey; Present address: Department of Radiology, Zonguldak Atatürk Hospital, Zonguldak, Turkey.
This article reviews how a specialized magnetic resonance imaging technique using a liver-specific contrast agent provides a non-invasive way to measure liver health and function, offering an alternative to traditional radioactive tracer tests and blood clearance methods.
Area of Science:
- Diagnostic radiology and hepatology research within hepatocyte-specific contrast-enhanced magnetic resonance imaging
- Clinical gastroenterology and imaging science
Background:
No prior work had resolved the limitations of traditional invasive liver function tests. Standard scintigraphy and clearance procedures often require radioactive tracers or complex blood sampling protocols. This gap motivated the development of non-invasive imaging biomarkers. It was already known that hepatocyte-specific contrast agents could highlight liver tissue. That uncertainty drove researchers to explore magnetic resonance imaging as a diagnostic tool. Prior research has shown that gadoxetic acid uptake reflects active hepatocyte transport. This paper addresses how such imaging provides a comprehensive assessment of liver health. No prior work had fully integrated these imaging metrics into clinical practice.
Purpose Of The Study:
The aim of this article is to evaluate the clinical utility of hepatocyte-specific contrast-enhanced magnetic resonance imaging for assessing liver function. This investigation addresses the need for non-invasive alternatives to traditional radioactive tracer tests. The authors explore how T1 mapping and signal intensity measurements provide quantitative biomarkers for hepatic health. This study examines the diagnostic potential of this imaging modality for various chronic liver diseases. The researchers investigate the role of hepatobiliary phase imaging in identifying localized and diffuse dysfunction. This work addresses the importance of preoperative functional assessment for oncologic hepatic surgery. The authors seek to clarify how functional magnetic resonance cholangiography aids in diagnosing complex biliary conditions. This review provides a comprehensive overview of the diagnostic advantages offered by gadoxetic acid administration.
Main Methods:
Review approach involves synthesizing clinical data on hepatocyte-specific contrast-enhanced imaging. The authors examine how T1 mapping and signal intensity measurements quantify liver performance. This investigation focuses on comparing modern imaging metrics against established scintigraphy and clearance procedures. The researchers analyze diagnostic capabilities for diverse pathologies including cirrhosis and fatty liver disease. Review approach covers the utility of hepatobiliary phase images for visual pattern recognition. The study evaluates the feasibility of preoperative remnant volume estimation for surgical planning. The authors assess the diagnostic accuracy of functional cholangiography for biliary tree disorders. This synthesis integrates findings from various clinical applications of gadoxetic acid.
Main Results:
Key findings from the literature indicate that hepatocyte-specific contrast-enhanced imaging serves as a robust biomarker for liver performance. The authors report that T1 mapping reduction rates provide quantitative data comparable to traditional clearance tests. Key findings from the literature show that signal intensity enhancement ratios effectively identify diffuse and segmental dysfunction. The researchers demonstrate that hepatobiliary phase images reveal pathology invisible to standard scans. Key findings from the literature highlight the utility of this method in diagnosing primary sclerosing cholangitis and toxic hepatitis. The study confirms that preoperative assessment helps estimate future remnant volume to mitigate surgical risks. Key findings from the literature suggest that functional cholangiography detects biliary leakage and sphincter issues. The authors note that functional data acquisition is straightforward when using gadoxetic acid.
Conclusions:
The authors propose that hepatocyte-specific contrast-enhanced imaging serves as a reliable biomarker for liver health. This approach offers a viable alternative to traditional scintigraphy and clearance tests. Synthesis and implications suggest that visual signal intensity analysis aids in identifying various dysfunction patterns. Preoperative evaluations using this method may assist in preventing post-surgical complications. The researchers indicate that functional cholangiography provides insights into biliary tree integrity. This technique allows for the detection of conditions like biliary leakage and sphincter dysfunction. The authors conclude that functional data acquisition is simplified through the use of specific contrast agents. These findings support the integration of advanced imaging into routine hepatobiliary diagnostics.
Frequently Asked Questions
The researchers propose that liver function is evaluated by measuring T1 mapping reduction rates and signal intensity enhancement ratios. This process utilizes gadoxetic acid as a contrast agent, which is taken up by hepatocytes, unlike traditional radioactive tracers used in scintigraphy or indocyanine green clearance tests.
The authors utilize gadoxetic acid, also known as Gd-EOB-DTPA, as the hepatocyte-specific contrast agent. This compound is necessary to visualize the hepatobiliary phase, which distinguishes this method from standard magnetic resonance imaging protocols that lack liver-specific functional uptake.
Functional magnetic resonance cholangiography is necessary to diagnose biliary conditions like acalculous cholecystitis and sphincter of oddi dysfunction. This specific imaging sequence relies on T1-weighted images captured during the hepatobiliary phase to visualize communication within the biliary tree.
The authors explain that hepatobiliary phase images are critical for identifying diffuse, lobar, or segmental liver dysfunction. These images provide the visual data required to differentiate between various patterns of injury that might remain invisible on standard non-contrast magnetic resonance scans.
The researchers propose that this imaging method estimates future remnant volume before oncologic surgery. This measurement is used to prevent posthepatectomy liver failure, providing a safer alternative to the clinical assessments performed before traditional invasive procedures.
The authors claim that this imaging modality enables the diagnosis of cirrhosis, nonalcoholic fatty liver disease, and toxic hepatitis. They suggest that these conditions are identifiable through specific signal intensity patterns that reflect underlying tissue fibrosis and steatohepatitis.
Related Concept Videos
Magnetic Resonance Imaging
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Imaging Studies IV: Magnetic Resonance Imaging
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...

